Balance Sheet
Accounts PayablesAccumulated ExpensesCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwill & IntangiblesInventoryLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhengye Biotechnology Holding (ZYBT) Total Current Liabilities: 2023-2024

Historic Total Current Liabilities for Zhengye Biotechnology Holding (ZYBT) over the last 2 years, with Dec 2024 value amounting to $18.6 million.

  • Zhengye Biotechnology Holding's Total Current Liabilities was N/A to $18.6 million in Q2 2025 from the same period last year, while for Jun 2025 it was $18.6 million, marking a year-over-year change of. This contributed to the annual value of $18.6 million for FY2024, which is 12.42% down from last year.
  • According to the latest figures from FY2024, Zhengye Biotechnology Holding's Total Current Liabilities is $18.6 million, which was down 12.42% from $21.3 million recorded in FY2023.
  • In the past 5 years, Zhengye Biotechnology Holding's Total Current Liabilities ranged from a high of $21.3 million in FY2023 and a low of $18.6 million during FY2024.
  • Its 2-year average for Total Current Liabilities is $19.9 million, with a median of $19.9 million in 2023.
  • Data for Zhengye Biotechnology Holding's Total Current Liabilities shows a maximum YoY declined of 12.42% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Zhengye Biotechnology Holding's Total Current Liabilities stood at $21.3 million in 2023, then dropped by 12.42% to $18.6 million in 2024.